baber/WOPTO huggingface dataset:
Patent WO-2019200105-A1 (WO)
Title: System and method of correlating multiple data points to create a new single data point
Inventor: LEKA DONALD
IPC: G06F16/00
Filed: 2019-04-11
Abstract: A system designed with a scanning engine, storage, analysis engine, search engine, security exchange, and display engine. The system performs data reticulation using the scanning engine to access a first piece of data stored at a first location and a second piece of data stored at a second location. The scanning engine further retrieves from the first and second pieces of data first and second metadata, related respectively. The analysis engine creates the correlated metadata based on the first and second metadata. An example of the correlated metadata contains information not present in the first metadata and the second metadata.
Patent WO-2019204166-A1 (WO)
Title: Apparatus and methods for enabling mobility of a user device in an enhanced wireless network
Inventor: JAYAWARDENE DIWELAWATTE
IPC: H04W16/14
Filed: 2019-04-12
Abstract: Apparatus and methods for unified high-bandwidth, low-latency data services provided with enhanced user mobility. In one embodiment, a network architecture having sendee delivery over at least portions of extant infrastructure (e.g., a hybrid fiber coax infrastructure) is disclosed, which includes standards-compliant ultra-low latency and high data rate services (e.g., 5G NR services) via a common service provider. Premises devices are used to provide the 5G-based services to users at a given premises and thereabouts. In another variant, local area (e.g., "pole mounted") radio devices are used to provide supplemental RF coverage, including during mobility^ scenarios. The 5G-capable network enables uninterrupted and "seamless" exchange of data at a client device by utilizing a common waveform protocol (e.g., 3GPP-based) at a premises device and an external radio device to communicate with a client device at different locations and times while the device is moving between inside and outside the premises.
Patent WO-2019204197-A1 (WO)
Title: Outsole plate
Inventor: BARTEL AARON
IPC: A43B13/02
Filed: 2019-04-15
Abstract: A sole structure for an article of footwear includes a component including a first bundle of fibers affixed to a substrate, a ground-engaging assembly including a first traction element, a second traction element, and a connecting member extending between and connecting the first traction element and the second traction element, and a resin consolidating the first bundle of fibers and entrapping the connecting member to fix a position of the first traction element, the second traction element, and the connecting member relative to the substrate.
Patent WO-2020214168-A1 (WO)
Title: Beam prediction for wireless networks
Inventor: KAYA ALIYE OZGE
IPC: H04B7/0408
Filed: 2019-04-17
Abstract: According to an example embodiment, a method may include determining, by a base station, a past beam sequence for a user equipment (UE), determining, by the base station based on the past beam sequence for the user equipment and a beam sequence model, a predicted future beam sequence for the user equipment, wherein the predicted future beam sequence indicates a predicted sequence of beams over time for communication between the user equipment and the base station, and performing, by the base station, a beam-related action based on the predicted future beam sequence for the user equipment.
Patent WO-2019210026-A1 (WO)
Title: Non-coordinating anion type activators containing cation having large alkyl groups
Inventor: FALER CATHERINE
IPC: C08F110/06
Filed: 2019-04-25
Abstract: The present disclosure provides borate or aluminate activators comprising cations having linear alkyl groups, catalyst systems comprising, and methods for polymerizing olefins using such activators. Specifically, the present disclosure provides activator compounds represented by Formula: [R1R2R3EH]d +[Mk+Qn]d-, wherein: E is nitrogen or phosphorous; d is 1, 2 or 3; k is 1, 2, or 3; n is 1, 2, 3, 4, 5, or 6; n - k = d; R1 is C1-C20 linear alkyl group; each of R2 and R3 is a C1-C40 linear alkyl group, a meta- and/or para-substituted phenyl group, an alkoxy group, a silyl group, a halogen, or a halogen containing group, wherein R1+R2+R3>15 carbon atoms; M is an element selected from group 13, typically B or Al; and each Q is independently a hydride, bridged or unbridged dialkylamido, halide, alkoxide, aryloxide, hydrocarbyl, substituted hydrocarbyl, halocarbyl, substituted halocarbyl, or halosubstituted-hydrocarbyl radical, provided that when Q is a fluorophenyl group, then R2 is not a C1-C40 linear alkyl group.
Patent WO-2019213482-A1 (WO)
Inventor: DZIKI JENNA LYNN
IPC: A61K35/12
Filed: 2019-05-03
Abstract: L'invention concerne des méthodes de traitement d'un sujet atteint d'un trouble tel que, mais sans limitation, a) la fibrose d'un organe ou d'un tissu ; b) un rejet de greffe d'organe solide ; ou c) une maladie cardiaque qui n'est pas un infarctus du myocarde ou une ischémie myocardique. Ces méthodes comprennent la sélection d'un sujet ayant ou risquant d'avoir le trouble, et l'administration au sujet d'une quantité thérapeutiquement efficace de nanovésicules isolées dérivées d'une matrice extracellulaire, les nanovésicules contenant de l'interleukine (IL)-33 et comprennent la lysyl oxydase, et les nanovésicules a) n'exprimant pas CD63 ou CD81, ou b) étant CD63loCD81lo. Dans d'autres modes de réalisation, l'invention concerne des procédés pour augmenter la différenciation des myoblastes.
Patent WO-2019217268-A1 (WO)
Inventor: ZHANG XIAOLIN
IPC: C08B37/08
Filed: 2019-05-06
Abstract: A composite material includes a polymer matrix with a polymer having D-glucosamine monomer units and 50% or fewer N-acetyl-D-glucosamine monomer units. A salt can be disposed in the polymer matrix. A dispersed phase is disposed in the polymer matrix with the salt, and the dispersed phase and the polymer matrix form a porous composite foam. The porous composite foam includes, by weight, 0.5 - 3 times the dispersed phase to the polymer matrix, and the porous composite foam has a density of less than 1 g/cm 3 .
Patent WO-2019217573-A1 (WO)
Inventor: SIVARAMAN HARI
IPC: G06F9/50
Filed: 2019-05-08
Abstract: L'invention concerne des aspects d'attribution de tâche pour des systèmes qui comprennent des unités de traitement graphique (GPU) qui sont activées par processeur graphique virtuel (vGPU). Dans certains exemples, un algorithme est déterminé sur la base d'algorithmes d'attribution de machine virtuelle prédéterminés. L'algorithme optimise pour une fonction de coût prédéterminée. Une machine virtuelle est mise en file d'attente dans une file d'attente d'arrivée pour une attribution. Une configuration graphique d'un système est déterminée. La configuration graphique spécifie un certain nombre d'unités de traitement graphique (GPU) dans le système. Le système comprend une GPU activée par vGPU. L'algorithme est sélectionné sur la base d'une corrélation entre l'algorithme et la configuration graphique du système. La machine virtuelle est attribuée à une file d'attente d'exécution sur la base de l'algorithme sélectionné.
Patent WO-2019222461-A1 (WO)
Title: Palladium hyaluronic acid particles and methods of managing cancer or angiogenic conditions
Inventor: ARBISER JACK
IPC: A61K31/728
Filed: 2019-05-16
Abstract: This disclosure relates to palladium hyaluronic acid particles such as dibenzylideneacetone palladium hyaluronic acid particles. In certain embodiments, this disclosure relates to methods of managing cancer or angiogenic conditions using particles disclosed herein and pharmaceutical compositions comprising the same. In certain embodiments, an objective of this disclosure is hyaluronic acid targeting of CD44, a tumor stem cell marker. In certain embodiments, this disclosure relates to treatment with hyaluronic acid palladium particles disclosed herein for depleting CD44 cells.
Patent WO-2019222551-A1 (WO)
Title: Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
Inventor: LUKE GEORGE P
IPC: C07D401/12
Filed: 2019-05-16
Abstract: The present disclosure reports solid forms of (( S )-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile.
Patent WO-2019241495-A1 (WO)
Title: Pharmaceutical composition and method for acute on chronic liver failure
Inventor: FANG MING
IPC: A61K31/495
Filed: 2019-06-13
Abstract: The present invention provides a composition and method for treating acute on chronical liver failure or a related disease. The method comprises administering to a subject a composition comprising trimetazidine dihydrochloride (1-[2,3,4-trimethoxybenzyl] piperazine dihydrochloride) (Trimetazidine or TMZ) according to a dosage regimen.
Patent WO-2021002851-A1 (WO)
Title: Inks including a resin in a dispersed phase
Inventor: KELEKAR RAJESH
IPC: B05D1/04
Filed: 2019-07-02
Abstract: An emulsion ink includes a carrier fluid, pigment particles, and a liquid resin. The carrier fluid is a dielectric, non-aqueous carrier fluid. The pigment particles are within the carrier fluid. The liquid resin is in a dispersed phase within the carrier fluid. The liquid resin is to be polymerized after the ink is applied to a substrate.
Patent WO-2020033421-A1 (WO)
Title: Embedded universal serial bus 2 repeater
Inventor: MAUNG WIN NAING
IPC: G06F13/40
Filed: 2019-08-06
Abstract: In some examples, a method (800) includes receiving, at a circuit, data via a differential input signal (805), detecting a rising edge in the data received via the differential input signal (810), and precharging a common mode voltage (Vcm) node of the differential input signal responsive to detecting the rising edge in the data received via the differential input signal (815). The Vcm node is a floating node.
Patent WO-2020033810-A1 (WO)
Title: Resume failure handling after cell reselection
Inventor: CHEN TEMING
IPC: H04W76/27
Filed: 2019-08-09
Abstract: This document describes techniques and apparatuses for the handling of an RRC connection resume procedure failure after cell reselection in a UE (110). In aspects, the UE (110) selects a first cell (121) and enters a radio resource inactive state with the first cell. The UE (110) detects a trigger from a lower layer or an upper layer of the UE (110). Responsive to detecting the trigger, the UE (110) starts a first timer. The trigger initiates an RRC connection resume procedure. Responsive to the trigger, the UE (110) transmits an RRC connection resume request message to the first cell (121). Before the first timer expires, the UE (110) initiates a cell reselection procedure to select a second cell (123). The UE (110) stops the RRC connection resume procedure and then enters a radio resource idle state.
Patent WO-2020041587-A1 (WO)
Title: Rotary cam operated release mechanism
Inventor: DOREY PETER JAMES
IPC: B63B35/03
Filed: 2019-08-22
Abstract: A release mechanism for a tether assembly. A circular base ring has a central opening sized to accept a connecting member, and a plurality of radial slots. Dogs are disposed in the radial slots, and movable radially inwardly and outwardly. A cam ring having angled slots is operatively connected to the base ring, with upturned ends on the dogs engaged in the angled slots. Relative rotation between the cam ring and the base ring, by hydraulic cylinders connecting the two rings, moves the dogs radially inwardly and outwardly. In their radially inward position the dogs engage a circumferential groove in an elongated connecting member, thereby connecting the tether assembly.
Patent WO-2020047070-A1 (WO)
Inventor: DONAT CHRISTOPHER
IPC: B01L3/00
Filed: 2019-08-28
Abstract: A fluid-holding vessel (28) with a surface tension reducing geometry which comprises an inner surface having striations (24) and a fluid transfer method are disclosed and described. The fluid-holding vessel (28) may be a test tube that is used in combination with a cap (20), which is penetrable by a fluid transfer device (11) of an automated analyzer (10) used to transfer fluids to or from the striated test tube, where the tube and cap may remain physically and sealably associated during a fluid transfer. The automated analyzer (10) may be used in combination with the fluid-holding vessel (28) as disclosed and described herein, in which the surface tension reducing geometry (24, 26) of the vessel (28) addresses an aspiration problem of a liquid (18) dispensed therefrom automatically by the automated analyzer (10), e.g., into a sample cup.
Patent WO-2020051219-A1 (WO)
Title: Systems and method for metering and timing of fluid flow in a point-of-care diagnostic cartridge
Inventor: CARRANO JOHN
IPC: B01L3/00
Filed: 2019-09-04
Abstract: A specimen processing cartridge includes a reservoir having a fluid inlet, an elastic diaphragm, and a fluid outlet. The reservoir is operable to receive a volume of liquid from the fluid inlet, and the fluid outlet is positioned along a fluid flow path between the reservoir and a downstream reservoir. The cartridge includes a dissolvable membrane that occludes flow through the fluid outlet when the dissolvable membrane is in a first, undissolved state, and that permits flow from the reservoir to the downstream reservoir when in a second, dissolved state. The elastic diaphragm is operable to pressurize the reservoir upon receiving the volume of liquid when the dissolvable membrane is in the first, undissolved state, and is operable to contract and propel at least a portion of the volume of liquid from the reservoir to the downstream reservoir when the dissolvable membrane is in the second, dissolved state.
Patent WO-2020061133-A1 (WO)
Inventor: LASTRA RAFAEL
IPC: E21B43/12
Filed: 2019-09-18
Abstract: Systems and methods for producing hydrocarbons from a subterranean well include a first electrical submersible pump section (46) having an outer motor body (48), and a motor stator (52). A central bore (50) extends through the motor body and is sized to accommodate a motor rotor assembly (66). A second electrical submersible pump section (62) has the motor rotor assembly (66), a seal section (32), and a pump section (30). The first electrical submersible pump section (46) has a downhole ring (54) shaped to secure the first electrical submersible pump section to a downhole production tubing (36), and has an uphole ring (58) shaped to secure the first electrical submersible pump section to an uphole production tubing (34). The second electrical submersible pump section (62) has a deployment connector (65) operable to connect to an installation line for rig-less installation and removal of the second electrical submersible pump section (62).
Patent WO-2020069025-A1 (WO)
Title: Radar spatial estimation
Inventor: LIU YU
IPC: G01S13/93
Filed: 2019-09-25
Abstract: Techniques are discussed for generating a spatial grid based on radar sensor data. The spatial grid may include cells, which may be designated as being occupied, occluded, and/or free space. A cell may be designated as being occupied if radar sensor data is associated with a region of an environment associated with the cell. A field may be designated as being occluded if a region of the environment associated with the cell is obstructed, relative to a radar sensor, by a cell that is designated as being occupied. In some instances, objects may be detected and/or tracked in occluded regions. A cell may be designated as being free space if a region associated with the cell is within a field of view of a radar sensor and is unoccupied and un-occluded. In some instances, the spatial grid may be used to control a vehicle, such as an autonomous vehicle, in the environment.
Patent WO-2020069347-A1 (WO)
Title: Biodegradation of fluorochemicals
Inventor: JAFFE PETER
IPC: C02F3/30
Filed: 2019-09-27
Abstract: Media are described herein for the degradation and/or remediation of fluorochemicals. Briefly, a medium comprises an electron donor; a fluorochemical component; an electron acceptor; and a Feammox bacterium and/or one or more enzymes exhibiting reductive dehalogenase activity, the Feammox bacterium and/or enzyme(s) capable of fluorochemical degradation in conjunction with oxidation of electron donor and electron transfer to the electron acceptor. In some embodiments, the fluorochemical component comprises one or more fluorochemicals selected from the group consisting of perfluoroalkyl compounds, polyfluoroalkyl compounds, fluorinated carboxylic acids, fluorinated alcohols, and fluorinated sulfonates. The medium, in some embodiments, comprises water, soil, sludge, sorbents and/or solids contaminated with the fluorochemical component.
Patent WO-2021061156-A1 (WO)
Inventor: GOOCH NATHAN
IPC: A61B5/103
Filed: 2019-09-27
Abstract: Medical devices and methods thereof for determining bacterial infections in blood. The medical devices and methods thereof can utilize a coating including an antibody conjugated to a reporter protein configured to indicate a bacterial infection in a patient's blood by way of an antigen thereof. Exemplary medical devices include, but are not limited to, a catheter assembly, an AV fistula needle set, an extension set for either a catheter assembly or an AV fistula needle set, and a hemodialysis tubing set. The medical devices and methods thereof can utilize immunochromatographic separation of the antibody and an antigen-antibody complex to indicate a bacterial infection in a patient's blood.
Patent WO-2020077348-A1 (WO)
Inventor: PERSCHEID ANDREAS
IPC: H04R25/02
Filed: 2019-10-14
Abstract: Hearing is tested by selection of one of twenty four playbacks of speech, for each ear. Cognitive training/testing exercises test and train the user to relearn to distinguish between various sounds and particularly speech using the hearing assistance device. The regimens for using the hearing aid depend upon the measured cognitive loss, with different sets of DSP parameters for self-directed, non-assessed cognitive training. An audiologist user interface and patient user interface include soundmaps and slidebars to control collections of hearing parameters within the DSP of the device. Based on cognitive testing and training of the patient, the range of adjustment allowed within at least the patient user interface is limited. The software therefore always maintains 100% safety for the patient and/or user to finetune the hearing aid parameters without worrying about selecting parameter values which would leading to slowing the cognitive learning of the patient.
Patent WO-2020092341-A1 (WO)
Title: Let-7 promotes anti-tumor activity of cd8 t cells and memory formation in vivo
Inventor: POBEZINSKY LEONID
IPC: A61P35/00
Filed: 2019-10-29
Abstract: Disclosed herein are compositions and methods for enhancing T-cell activity by modulating a miRNA so as to improve T-cell therapies. Described herein is the discovery that miRNA (Iet7) regulates T cell responses (including both T-helpers and cytotoxic CD8 Lymphocyte (CTLs)). Described herein are compositions and methods to increase the cytotoxic activity of CTLs and improve cancer immunotherapies.
Patent WO-2020101992-A1 (WO)
Inventor: FARLEY HERBERT M
IPC: A01D41/14
Filed: 2019-11-07
Abstract: A header (112) of a harvester (100) includes a first header segment (212) comprising a cutter bar (202) configured to cut crops, and a first portion of a conveyor assembly (208). The header (112) additionally includes a center section (211) comprising a second portion of the conveyor assembly (208), wherein the center section (211) is configured to receive cut crops from the first header segment (212) via the first portion of the conveyor assembly (208). The header (112) also includes a first wheel (226) configured to at least partially support a weight of the header (112), and a first sensor (610) configured to output a signal indicative of a distance to ground. The header (112) further includes a first actuator (510) coupling the first wheel (226) to the header (112); and a control system (650) comprising a processor (652) configured to receive a sensor signal from the first sensor (610) and to control the first actuator (510) to adjust the first wheel (226) based on the sensor signal.
Patent WO-2020102245-A1 (WO)
Title: In-flow photooxygenation of aminothienopyridinones generates novel ptp4a3 phosphatase inhibitors
Inventor: LAZO JOHN
IPC: A61K31/4365
Filed: 2019-11-12
Abstract: The disclosure provides compounds that inhibit protein tyrosine phosphatase, such as protein tyrosine phosphatase 4A3 (PTP4A3). The disclosure also provides pharmaceutical compositions, uses, and methods of using the compounds, such as in the treatment of cancers. (I), wherein X is O or NH.
Patent WO-2020132003-A1 (WO)
Title: Internal carotid artery thrombectomy devices and methods
Inventor: KALLMES DAVID
IPC: A61M25/00
Filed: 2019-12-18
Abstract: The disclosure includes a balloon guiding sheath including an elongated sheath having a proximal end, a distal end, an inner tube and an outer tube both extending between the proximal end and the distal end, an access port located adjacent the proximal end, a distal port located adjacent the distal end, and a working lumen extending through the elongated sheath between the access port and the distal port. The balloon guiding sheath may include an inflatable balloon located on an outer surface of the elongated sheath adjacent the distal end, and at least one vent hole located between an outer surface of the elongated sheath and an inner surface of the inflatable balloon. The at least one vent hole may be configured to allow media to flow from the inflatable balloon to an external portion outside the balloon guiding sheath.
Patent WO-2020142213-A1 (WO)
Inventor: FESSLER RICHARD G
IPC: A61B17/00
Filed: 2019-12-18
Abstract: La présente invention concerne un système de fixation osseuse prévu pour l'utilisation dans la colonne vertébrale entre les vertèbres. Le système comprend un premier système de fixation configuré pour l'ancrage dans une première vertèbre, un second système de fixation configuré pour l'ancrage dans une seconde vertèbre, et une vis de réglage pour retenir le second système de fixation au premier système de fixation. Le premier système de fixation comprend une tige s'étendant le long d'un axe longitudinal et d'une tête. La tige comprend un premier corps cylindrique. La tête du premier système de fixation comprend un second corps cylindrique définissant une voie de passage ayant une surface intérieure. La voie de passage définit un axe longitudinal qui est différent de l'axe longitudinal de la tige. Le premier corps cylindrique de la tige et le second corps cylindrique de la tête sont inclinés l'un par rapport à l'autre. Le second système de fixation comprend une tige et une tête. La tête du second système de fixation est configurée pour engager la surface intérieure de la voie de passage de la tête du premier système de fixation. La vis de réglage engage également la surface intérieure de la voie de passage et retient la tête du second système de fixation dans la voie de passage.
Patent WO-2020142734-A1 (WO)
Inventor: MIAO HONGLEI
IPC: H04L1/00
Filed: 2020-01-03
Abstract: Embodiments disclosed herein can enable multi-TRP transmission for PDCCH to achieve diversity gain for the potential benefits to URLLC use cases with challenging reliability/robustness requirements. Specifically, multi-TRP transmission for PDCCH can be performed at different levels as follows: 1. PDCCH with multi-TRP transmission on repetition level; 2. PDCCH with multi-TRP transmission on CCE level; and/or 3. PDCCH with multi-TRP transmission on REGB level.
Patent WO-2020150496-A1 (WO)
Title: Formulations of antibodies that bind human cd137 and uses thereof
Inventor: ZARBIS-PAPASTOITSIS GRIGORIOS
IPC: C07K16/28
Filed: 2020-01-16
Abstract: The present disclosure relates to, inter alia, stable formulations comprising an antibody that binds human CD 137 or antigen binding fragments thereof, and to use of the formulations in methods for treating, or ameliorating various diseases and conditions, including cancer, that are amenable to treatment with a CD 137 antibody.